InvestorsHub Logo
Followers 30
Posts 2225
Boards Moderated 0
Alias Born 12/13/2016

Re: powerwalker post# 141641

Monday, 02/19/2018 3:38:22 PM

Monday, February 19, 2018 3:38:22 PM

Post# of 469971
Power, Your assumptions are as good as mine. Sure would help if we had access to the wording in the MTA. Don't know about offline testing in humans but , it is possible that further human testing could be conducted under the auspices of some other national authority as was our P1 human test conducted in Germany by ABX-CRO (see PR below). As noted all clinical trials need/are not registered on Clinical Trials.gov.

Reviewing Opicinumab on that site, it is listed as "recruiting" for a 240 patient P2 and described as an "Add-on therapy to other Disease Modifying Therapies". The results of the initial optic nerve trial are documented there too.

Just can't see 2-73 gathering dust on the shelf in the foremost MS laboratories in the world at Biogen and WSU...at least not for long!

----

http://anavex.com/anavex-receives-approval-to-commence-phase-i-clinical-trial-in-alzheimers-disease/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News